Di'An Diagnostics

active

The proposed investment will support Di’An Diagnostics Group Co., Ltd. (“Di’An”, “the Company” or “the Borrower”) to (i) expand and upgrade its existing ICL network and create 5 regional test centers through expansion of existing ICLs; (ii) add 5 “spoke” ICLs in second/third tier cities; (iii) build a manufacturing center for its self-developed In Vitro Diagnostic (“IVD”) products; (iv) fund R&D expenses to accelerate expansion in specialized testing and (v) build advanced IT infrastructure and data analytics function over the next five years (together, the “Project”). The additional testing capacity created by the Project will help to relieve capacity constraints at over-crowded public hospitals while expanding the types of testing available.